ELF stock spiked on Thursday after the Oakland, Calif.-based cruelty-free cosmetics maker posted a massive quarterly beat late Wednesday.
ELF Beauty's Q3 adjusted earnings doubled to 48 cents per share and blew away FactSet consensus estimates for a decline to 23 cents per share. Meanwhile, revenue rose more than 49% to $146.5 million for the third quarter.
ELF Beauty, a recent IBD Stock Of The Day, has seen earnings accelerate the past three quarters while sales gains sped up the last four quarters. Earnings and revenue topped analyst estimates in all four recent quarters.
ELF Stock
ELF stock spiked 15% Thursday, rising to an all-time high of 67.29. Shares had recovered above support at the 10-week moving average, after a failed breakout triggered the automatic sell rule in mid-January. The beauty products company's shares rallied 75% after breaking out from its cup base at the end of July.
ELF Beauty stock leads the IBD Cosmetics/Personal Care Group according to the IBD Stock Checkup. It has a near-perfect 98 RS Rating, meaning it has outperformed 98% of its market peers. ELF has a 92 EPS Rating due to its consistently positive earnings. And it has a 98 Composite Rating out of 99, which combines a number of key technical indicators into one score.
ELF shares are up nearly 21% over the past month and 40% over the past three months.
You can follow Harrison Miller for more stock news and updates on Twitter @IBD_Harrison
